Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas
Alicia León‐Castillo(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Tjalling Bosse(Leiden University Medical Center), Beth Harrison(Brigham and Women's Hospital), Joseph W. Carlson(Karolinska University Hospital), Raji Ganesan(Birmingham Women’s and Children’s NHS Foundation Trust), Sara Y. Brucker(University Children's Hospital Tübingen), Melissa K. McConechy(Contextual Change (United States)), Esther Oliva(Agostino Gemelli University Polyclinic), Robert A. Soslow(Cleveland Clinic), Jessica N. McAlpine(University of British Columbia), David N. Church(Centre for Human Genetics), Xavier Matías‐Guiu(Universitat de Lleida), Ester Gilvazquez(Centre for Human Genetics), Tilman T. Rau(University of Bern), Vincent T.H.B.M. Smit(Leiden University Medical Center), C. Blake Gilks(Fox Chase Cancer Center), E. Epstein(Karolinska Institutet), Stefan Kommoss(University Children's Hospital Tübingen), Remi A. Nout(Erasmus MC Cancer Institute)
Cited by 401
Related Papers
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k
The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies
|Clinical and Translational Radiation Oncology|2018|932
<scp>FIGO</scp> staging of endometrial cancer: 2023
|International Journal of Gynecology & Obstetrics|2023|926
Type I and II Endometrial Cancers: Have They Different Risk Factors?
|Journal of Clinical Oncology|2013|833
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer
|International Journal of Gynecological Cancer|2015|757